M Remzi

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Urol 176:896-9. 2006
  2. ncbi Morbidity of laparoscopic extraperitoneal versus transperitoneal radical prostatectomy verus open retropubic radical prostatectomy
    M Remzi
    Department of Urology, University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Eur Urol 48:83-9; discussion 89. 2005
  3. ncbi Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how?
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Vienna, Austria
    Eur Urol 55:359-67. 2009
  4. ncbi Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Vienna, Austria
    BJU Int 99:1002-6. 2007
  5. ncbi Management of small renal masses: a review
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    World J Urol 28:275-81. 2010
  6. ncbi [Small incidental renal tumors. Evaluation and biological parameters]
    M Remzi
    Urologische Universitätsklinik, Medizinische Universitat, A 1090 Wien
    Urologe A 46:478, 480-4. 2007
  7. ncbi Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Mesut Remzi
    Department of Urology, University of Vienna, Wahringer Gurtel 18 20, Austria
    Eur Urol 46:451-6. 2004
  8. ncbi Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study
    B Djavan
    Department of Urology University of Vienna, Vienna, Austria
    Prostate 47:111-7. 2001
  9. ncbi Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression
    R Wammack
    Department ofUrology, University Hospital of Vienna, Vienna, Austria
    Urology 58:1004-7. 2001
  10. ncbi Modified laparoscopic nephroureterectomy for treatment of upper urinary tract transitional cell cancer is not associated with an increased risk of tumour recurrence
    H C Klingler
    Department of Urology, University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Eur Urol 44:442-7. 2003

Detail Information

Publications44

  1. ncbi Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Urol 176:896-9. 2006
    ..This assumption is mainly based on the low tendency to increase in size on serial imaging studies, but histopathological parameters of progression in larger patient series are scant...
  2. ncbi Morbidity of laparoscopic extraperitoneal versus transperitoneal radical prostatectomy verus open retropubic radical prostatectomy
    M Remzi
    Department of Urology, University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Eur Urol 48:83-9; discussion 89. 2005
    ..Morbidity and postoperative pain after extraperitoneal (E-LRPE) and transperitoneal (T-LRPE) laparoscopic radical prostatectomy was compared to open extraperitoneal radical prostatectomy (O-RPE)...
  3. ncbi Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how?
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Vienna, Austria
    Eur Urol 55:359-67. 2009
    ....
  4. ncbi Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Vienna, Austria
    BJU Int 99:1002-6. 2007
    ..To compare histopathological findings as a function of radiological tumour size, as published data suggest that small renal tumours are often benign and large tumours are renal cell cancer (RCC)...
  5. ncbi Management of small renal masses: a review
    Mesut Remzi
    Department of Urology, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    World J Urol 28:275-81. 2010
    ..Standard treatment for SRMs is nephron-sparing surgery (NSS). New techniques like energy ablation and surveillance have been introduced...
  6. ncbi [Small incidental renal tumors. Evaluation and biological parameters]
    M Remzi
    Urologische Universitätsklinik, Medizinische Universitat, A 1090 Wien
    Urologe A 46:478, 480-4. 2007
    ..Percutaneous renal mass biopsy has an accuracy of over 90% for detecting benign lesions and can influence therapeutic decisions, especially in patients with higher surgical risk...
  7. ncbi Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Mesut Remzi
    Department of Urology, University of Vienna, Wahringer Gurtel 18 20, Austria
    Eur Urol 46:451-6. 2004
    ..5 and 10 ng/ml and to evaluate its impact on prostate cancer (PCa) detection in men undergoing first and repeat biopsies...
  8. ncbi Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study
    B Djavan
    Department of Urology University of Vienna, Vienna, Austria
    Prostate 47:111-7. 2001
    ....
  9. ncbi Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression
    R Wammack
    Department ofUrology, University Hospital of Vienna, Vienna, Austria
    Urology 58:1004-7. 2001
    ..No differences were noted in pain apprehension or early and delayed morbidity, suggesting that TRUS-guided biopsies can be performed safely in these patients...
  10. ncbi Modified laparoscopic nephroureterectomy for treatment of upper urinary tract transitional cell cancer is not associated with an increased risk of tumour recurrence
    H C Klingler
    Department of Urology, University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Eur Urol 44:442-7. 2003
    ..We evaluated results obtained from patients undergoing a modified laparoscopic approach and open procedures in this respect...
  11. ncbi Benefits of laparoscopic renal surgery are more pronounced in patients with a high body mass index
    H C Klingler
    Department of Urology, University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Eur Urol 43:522-7. 2003
    ..Aim of this prospective study was to determine whether patients with a higher body mass index (BMI) will benefit more from laparoscopic procedures in respect to postoperative morbidity and pain as compared to regular patients...
  12. ncbi Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study
    B Djavan
    Department of Urology, University Hospital of Vienna, Vienna, Austria
    J Urol 166:856-60. 2001
    ..Re-biopsy can be performed 6 weeks later with no significant difference in pain or morbidity. Patients younger than 60 years should be counseled in regard to a higher level of discomfort, and local and topical anesthesia if desired...
  13. ncbi Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months
    B Djavan
    Department of Urology, University of Vienna, Vienna, Austria
    Urology 57:66-70. 2001
    ..The more favorable results in patients who underwent microwave treatment were maintained for at least 18 months...
  14. ncbi Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC
    Matthias Waldert
    Department of Urology, Medical University of Vienna, Vienna, Austria
    BJU Int 102:1381-4. 2008
    ..To compare the pathological features of clear cell renal cell carcinoma (ccRCC) with papillary RCC (pRCC) and further differentiate type I and II pRCC as independent prognosticators for survival...
  15. ncbi External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery
    Matthias Waldert
    Department of Urology, Medical University of Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    World J Urol 28:531-5. 2010
    ..The objective of this study is to provide a bi-center external validation of this classification using the technique of hilar arterial clamping during open and laparoscopic NSS and to correlate the PADUA score to the ischemia time...
  16. ncbi Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance
    Christian Seitz
    Department of Urology, Medical University of Vienna, Austria
    Eur Urol 49:1099-105; discussion 1105-6. 2006
    ..To investigate the relationship between delay in extracorporeal shock wave lithotripsy (ESWL) after a first colic and subsequent time to complete stone clearance...
  17. ncbi Extracorporeal shock wave lithotripsy in the treatment of proximal ureteral stones: Does the presence and degree of hydronephrosis affect success?
    Christian Seitz
    Department of Urology, Medical University of Vienna, Vienna, Austria
    Eur Urol 49:378-83. 2006
    ..We investigated the relation between the presence and degree of stone induced hydronephrosis and the outcome of extracorporeal shock wave lithotripsy (SWL) in patients with solitary proximal ureteral stones...
  18. ncbi Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma
    Tobias Klatte
    Department of Urology, Medical University of Vienna, Vienna, Austria
    J Urol 184:53-8. 2010
    ..We developed and externally validated a prognostic nomogram specifically for papillary renal cell carcinoma...
  19. ncbi The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume
    Mesut Remzi
    Department of Urology, University of Vienna, Vienna, Austria
    J Urol 174:1256-60; discussion 1260-1; author reply 1261. 2005
    ....
  20. ncbi Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses
    Joerg Schmidbauer
    Department of Urology, Medical University of Vienna, Vienna, Austria
    Eur Urol 53:1003-11. 2008
    ..Information that would be helpful when choosing the most appropriate management strategy for this patient group could be obtained from pretherapeutic image-guided biopsy...
  21. ncbi Prostate biopsy: who, how and when. An update
    Bob Djavan
    Department of Urology, University of Vienna, Vienna, Austria
    Can J Urol 12:44-8; discussion 99-100. 2005
    ..Power Doppler TRUS will further enhance prostate cancer detection as will artificial neural networks as patient selecting tools...
  22. ncbi An artificial neural network to predict the outcome of repeat prostate biopsies
    Mesut Remzi
    Department of Urology, University of Vienna, Vienna, Austria
    Urology 62:456-60. 2003
    ..By combining the individual clinical and biochemical markers into the ANN, 68% specificity at 95% sensitivity was achieved. The ANN allows more accurate and individual counseling of patients with a negative initial biopsy...
  23. ncbi Repeat prostate biopsy: who, how and when?. a review
    Bob Djavan
    Department of Urology, University of Vienna, Vienna, Austria
    Eur Urol 42:93-103. 2002
    ..Indications and ideal number of biopsy cores to take when repeating biopsies in patients who already underwent extensive biopsy protocols on the first biopsy remains to be determined...
  24. ncbi Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy?
    M Remzi
    Department of Urology, University of Vienna, Vienna, Austria
    Urology 61:161-6. 2003
    ..3 cm3) and large (greater than 41 cm3) TZ volumes, was very low. Therefore, a repeat prostate biopsy within 6 weeks is unnecessary. These patients should be followed up by serial PSA determination...
  25. ncbi Novel artificial neural network for early detection of prostate cancer
    Bob Djavan
    Department of Urology, University of Vienna, Austria
    J Clin Oncol 20:921-9. 2002
    ..5 to 4 ng/mL and from 4 to 10 ng/mL were prospectively developed. The predictive accuracy of the ANN was compared with that obtained by use of conventional statistical analysis of standard PSA parameters...
  26. ncbi A delay in radical nephroureterectomy can lead to upstaging
    Matthias Waldert
    Medical University of Vienna, Vienna, Austria
    BJU Int 105:812-7. 2010
    ..Study Type - Prognosis (case series) Level of Evidence 4..
  27. ncbi The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy
    Matthias Waldert
    Department of Urology, Medical University of Vienna, Vienna, Austria
    BJU Int 103:66-70. 2009
    ....
  28. ncbi Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients
    Tobias Klatte
    Department of Urology, Medical University of Vienna, Austria
    BJU Int 105:1260-5. 2010
    ..To outline the features and outcomes of renal cell carcinoma (RCC) in native kidneys of renal transplant recipients, who are at increased risk of developing this disease...
  29. ncbi Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-sp
    Bob Djavan
    Department of Urology, University of Vienna, Austria
    Urology 60:4-9. 2002
    ..In addition, cPSA and cPSA volume-related parameters (cPSAD, cPSAD of the transition zone) further improved the specificity of PSA in early detection of prostate cancer...
  30. ncbi When to biopsy and when to stop biopsying
    Bob Djavan
    Department of Urology, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Urol Clin North Am 30:253-62, viii. 2003
    ..For the initial biopsy, the optimal number of biopsy cores for detecting prostate cancer in prostate biopsy remains controversial; it is also often unclear who should undergo a repeat prostatebiopsy and when to stop biopsying...
  31. ncbi 'Skipping' is still a problem with radiofrequency ablation of small renal tumours
    H Christoph Klingler
    Department of Urology, Medical University of Vienna, Vienna, Austria
    BJU Int 99:998-1001. 2007
    ....
  32. ncbi Nephrovesical subcutaneous ureteric bypass: long-term results in patients with advanced metastatic disease-improvement of renal function and quality of life
    Joerg Schmidbauer
    Department of Urology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Eur Urol 50:1073-8; discussion 1078. 2006
    ..Placing a percutaneous nephrostomy often is the only and final solution for patients with metastatic disease, where internal ureteral stenting proved to be impossible...
  33. ncbi Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study
    Bob Djavan
    Department of Urology University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur Urol 47:38-44; discussion 44. 2005
    ..Pathological and biochemical features of prostate cancers detected on repeat biopsies in men with total PSA level between 2.0 and 4 ng/ml were evaluated and compared to those cancers detected on first biopsy...
  34. ncbi Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients
    Mazda Memarsadeghi
    Division of Angiography and Interventional Radiology, Department of Radiology, General Hospital of Vienna, Medical University Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Eur J Radiol 59:183-9. 2006
    ..To evaluate the outcome of 16 patients after percutaneous radiofrequency ablation of renal tumors...
  35. ncbi Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer
    Georg Schatzl
    Department of Urology, Medical University of Vienna, Vienna, Austria
    Urology 65:1141-5. 2005
    ..High-grade PCa is associated with a low serum testosterone level, and the testosterone level has been negatively correlated with the expression of PSA...
  36. ncbi Comparison of open versus laparoscopic pyeloplasty techniques in treatment of uretero-pelvic junction obstruction
    H Christoph Klingler
    Department of Urology, University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Eur Urol 44:340-5. 2003
    ..Aim of this study was to evaluate laparoscopic dismembering pyeloplasty compared with other laparoscopic techniques and open surgery in this respect...
  37. ncbi Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene
    Michela de Martino
    Ludwig Boltzmann Cluster of Urology, Medical University of Vienna, Vienna, Austria
    J Urol 183:878-83. 2010
    ..We outlined the putative significance of GST in renal cell carcinoma biology by investigating the influence of its deletion polymorphisms on renal cell carcinoma progression...
  38. ncbi PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium
    Bob Djavan
    Department of Urology, University of Vienna, Waehringer Guertel 18 20, Vienna A 1090, Austria
    Eur Urol 43:12-27. 2003
    ..At last, the use of artificial neural networks will certainly enhance the selection of patients submitted to radical treatments as well as the selection of relapsing patients to allow a more appropriate adjuvant therapy...
  39. ncbi Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients
    Mesut Remzi
    Medical University of Vienna, Vienna, Austria
    BJU Int 103:307-11. 2009
    ....
  40. ncbi An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less
    Alexandre R Zlotta
    Department of Urology, Erasme Hospital, University Clinics of Brussels, Brussels, Belgium
    J Urol 169:1724-8. 2003
    ..In the future artificial neural networks may represent a significant step for improved staging of prostate cancer when counseling patients referred for radical prostatectomy or other curative treatments...
  41. ncbi Haemostasis in laparoscopy
    Christoph H Klingler
    Department of Urology, Medical University of Vienna, Austria
    Eur Urol 50:948-56; discussion 956-7. 2006
    ..The aim of this review is to give insight into the most important tools and strategies to achieve sufficient haemostasis during advanced urologic laparoscopy...
  42. ncbi Editorial comment on: Improved accuracy in predicting the presence of gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy
    Mesut Remzi
    Eur Urol 52:1668-9. 2007
  43. ncbi Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men
    Carsten Stephan
    Department of Urology, Charite Universitatsmedizin Berlin, CCM, Berlin, Germany
    World J Urol 25:95-103. 2007
    ..Therefore, for each patient population, PSA assay-specific ANNs should be used to optimize the ANN outcome in order to reduce the number of unnecessary biopsies...
  44. ncbi Artificial neural networks for decision-making in urologic oncology
    Theodore Anagnostou
    Department of Urology, Athens General Hospital G Gennimatas, Athens, Greece
    Eur Urol 43:596-603. 2003
    ..The authors conclude that both methods should continue to be used in a complementary manner. ANNs still do not prove always better as to replace standard statistical analysis as the method of choice in interpreting medical data...